Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01208493
Other study ID # 04.26.INF
Secondary ID
Status Terminated
Phase N/A
First received September 22, 2010
Last updated March 25, 2015
Start date September 2007
Est. completion date April 2012

Study information

Verified date December 2011
Source Nestlé
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula.

Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a minimum of 3 weeks. The weight gain (g/d) will be measured and compared between groups. Feeding tolerance, protein-energy status and body composition between the study groups will also be analysed.

After discharge, babies will be fed a post-discharge preterm infant formula (PDF) between hospital discharge and 3 m corrected age.


Recruitment information / eligibility

Status Terminated
Enrollment 70
Est. completion date April 2012
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 10 Weeks
Eligibility Inclusion Criteria:

- Gestational age <32 w, determined by maternal dates, fetal ultrasound, Dubowitz/Ballard examination or a combination thereof

- Birth weight =1500 g

- Tolerating an enteral intake of =100 ml/kg/d for = 24 h

- Subject is anticipated to receive the study formula for = 3 consecutive weeks after FEF have been achieved

- In infants fed human milk, formula is anticipated to provide 50% or more of total energy intake, calculated on a weekly basis and based on the assumption that human milk has an energy density of 67 kcal/dl

- Written informed consent has been obtained from the legal representative

Exclusion Criteria:

- Cardiac failure requiring fluid restriction with diuretic therapy for = 3 consecutive days

- Peri-/intra-ventricular haemorrhage (grade 3-4) determined using cranial ultrasonography

- Renal disease: by symptoms (oliguria, anuria, proteinuria, hematuria) associated with an increased BUN and creatinine

- Sepsis: defined by symptoms requiring antibiotic therapy and confirmed by a positive blood culture

- Necrotizing Enterocolitis: defined by feeding intolerance associated with positive x-ray findings (pneumatosis intestinalis - Bell Stage 2; air in the biliary tract or free air in the peritoneum - Bell Stage 3)

- Hepatic dysfunction: defined by jaundice (direct bilirubin >1.0 mg/dl) which is associated with one or more abnormal liver function tests (AST, ALT or GGT)

- Lung disease, severe enough to require steroid therapy.

- Small size for gestational age (SGA) - body weight = 5th percentile for that gestational age.

- Participation in another clinical trial that may affect outcomes of this study

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
preterm infant formula with high protein levels
minimum 3 weeks feeding until hospital discharge
preterm standard infant formula
minimum 3 weeks feeding until hospital discharge

Locations

Country Name City State
Belgium Service Universitaire de Néonatologie CHR de la Citadelle Liège
France Service de néonatologie Hôpital de la Croix Rousse Lyon
United Kingdom Department of Child Health Royal Victoria Infirmary Newcastle upon Tyne
United States Department of Pediatrics St Louis University Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Nestlé

Countries where clinical trial is conducted

United States,  Belgium,  France,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary comparison of weight gain between both study groups as a measure of safety 3 weeks No
Secondary comparison of feeding tolerance and metabolic status between study groups as a measure of safety 3 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT03670732 - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure N/A
Completed NCT05322161 - Yoga in the NICU for Parents Study N/A
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Recruiting NCT04911452 - Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants N/A
Recruiting NCT02901652 - NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome N/A
Completed NCT02148965 - Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial N/A
Completed NCT02273843 - A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis Phase 1
Terminated NCT02032511 - Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP) N/A
Completed NCT01721629 - Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants N/A
Terminated NCT01819532 - Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks N/A
Completed NCT00951860 - Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort N/A
Completed NCT01523769 - Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants N/A
Completed NCT01478711 - Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants N/A
Completed NCT00749008 - Study of Generalized Movements for Early Prediction of Cerebral Palsy N/A
Completed NCT00787124 - Transfusions and Nitric Oxide Level in Preterm Infants
Completed NCT00527956 - Facilitation and Barriers to Breastfeeding in the NICU N/A
Terminated NCT00486395 - Will CPAP Reduce Length Of Respiratory Support In Premature Infants? Phase 3
Completed NCT03372590 - NEO Rehab for Infants at Risk of Cerebral Palsy N/A
Completed NCT00033917 - Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial Phase 3
Completed NCT05508308 - Automated Versus Manual Control Of Oxygen For Preterm Infants On Continuous Positive Airway Pressure In Nigeria N/A